|
|
Eli Lilly agrees to buy ImClone for over $6B
NEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.
Nations:U.S. People:Carl Icahn Source:(AP)
2008-10-06
New treatments extend brain cancer survival a bit
Malignant brain tumors remain one of the deadliest types of cancer, but new treatments have extended the lives of patients a bit in the past decade, and researchers say further advances may be on the horizon.
People:Edward Kennedy
2008-05-21
Genentech reports jump in 1Q earnings
Biotechnology giant Genentech Inc. is reporting a jump in its first-quarter profit of 12 percent compared to last year, but sales of its top-selling cancer drug disappointed Wall Street analysts.
2008-04-11
Test tells source of mystery cancers-researchers
Corrects 13th paragraph to show company is not seeking FDA approval but approval by CLIA, part of the federal Center for Medicare Services)
Nations:U.S.
2008-03-23
AstraZeneca's Recentin fails lung cancer trial
AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
2008-02-27
|